Much of the outrage targeting pharmaceutical companies over the past year has been focused on what many view to be the ugly side of free markets. 

As a result, many consumer advocates have pushed for the government to impose greater restrictions on the drug industry to prevent rapacious actors such as Martin Shkreli from putting profit over people. 

But a new report from Harvard claims that it's government policies that protect and accommodate pharmaceutical companies that has led to such high prices

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.